{
    "root": "cf3405b0-5d45-4bfc-bd77-dd330fe9f04f",
    "code": "34391-3",
    "codeSystem": "2.16.840.1.113883.6.1",
    "displayName": "HUMAN PRESCRIPTION DRUG LABEL",
    "name": "Clobazam",
    "value": "20250110",
    "ingredients": [
        {
            "name": "Clobazam",
            "code": "2MRO291B4U",
            "chebi_id": "http://purl.obolibrary.org/obo/CHEBI_31413"
        },
        {
            "name": "MAGNESIUM ALUMINUM SILICATE",
            "code": "6M3P64V0NC",
            "drugbank_id": "https://go.drugbank.com/drugs/DB11230"
        },
        {
            "name": "XANTHAN GUM",
            "code": "TTV12P4NEE",
            "chebi_id": "http://purl.obolibrary.org/obo/CHEBI_189560"
        },
        {
            "name": "CITRIC ACID MONOHYDRATE",
            "code": "2968PHW8QP",
            "chebi_id": "http://purl.obolibrary.org/obo/CHEBI_31404"
        },
        {
            "name": "SODIUM PHOSPHATE, DIBASIC, DIHYDRATE",
            "code": "94255I6E2T",
            "chebi_id": "http://purl.obolibrary.org/obo/CHEBI_37586"
        },
        {
            "name": "DIMETHICONE",
            "code": "92RU3N3Y1O",
            "drugbank_id": "https://go.drugbank.com/drugs/DB11074"
        },
        {
            "name": "POLYSORBATE 80",
            "code": "6OZP39ZG8H",
            "chebi_id": "http://purl.obolibrary.org/obo/CHEBI_53426"
        },
        {
            "name": "METHYLPARABEN",
            "code": "A2I8C7HI9T",
            "chebi_id": "http://purl.obolibrary.org/obo/CHEBI_31835"
        },
        {
            "name": "PROPYLPARABEN",
            "code": "Z8IX2SC1OH",
            "chebi_id": "http://purl.obolibrary.org/obo/CHEBI_32063"
        },
        {
            "name": "PROPYLENE GLYCOL",
            "code": "6DC9Q167V3",
            "chebi_id": "http://purl.obolibrary.org/obo/CHEBI_13643"
        },
        {
            "name": "SUCRALOSE",
            "code": "96K6UQ3ZD4",
            "chebi_id": "http://purl.obolibrary.org/obo/CHEBI_32159"
        },
        {
            "name": "MALTITOL",
            "code": "D65DG142WK",
            "chebi_id": "http://purl.obolibrary.org/obo/CHEBI_68428"
        },
        {
            "name": "WATER",
            "code": "059QF0KO0R",
            "chebi_id": "http://purl.obolibrary.org/obo/CHEBI_15377"
        },
        {
            "name": "SILICON DIOXIDE",
            "code": "ETJ7Z6XBU4",
            "chebi_id": "http://purl.obolibrary.org/obo/CHEBI_30563"
        }
    ],
    "indications": {
        "text": "clobazam oral suspension indicated adjunctive treatment seizures associated lennox-gastaut syndrome ( lgs ) patients 2 years age older .",
        "doid_entities": [
            {
                "text": "lennox-gastaut syndrome (DOID:0050561)",
                "doid_id": "http://purl.obolibrary.org/obo/DOID_0050561"
            },
            {
                "text": "syndrome (DOID:225)",
                "doid_id": "http://purl.obolibrary.org/obo/DOID_225"
            }
        ],
        "orphanet_entities": [
            {
                "disease": "lennox-gastaut syndrome",
                "orphanet_id": "http://www.orpha.net/ORDO/Orphanet_2382"
            }
        ]
    },
    "contraindications": {
        "text": "doses 5 mg/day administer two divided doses . ( 2.1 ) patients \u2264 30 kg body weight : initiate 5 mg daily titrate tolerated 20 mg daily . ( 2.1 ) patients > 30 kg body weight : initiate 10 mg daily titrate tolerated 40 mg daily . ( 2.1 ) adjustment needed following groups : geriatric patients ( 2.4 , 8.5 ) known cyp2c19 poor metabolizers ( 2.5 ) mild moderate hepatic impairment ; information severe hepatic impairment ( 2.7 , 8.8 ) oral suspension : taken without food . ( 2.3 )",
        "doid_entities": [],
        "orphanet_entities": [
            {
                "disease": "severe hepatic impairment",
                "orphanet_id": "http://www.orpha.net/ORDO/Orphanet_447788"
            }
        ]
    },
    "warningsAndPrecautions": "clobazam oral suspension , 2.5 mg/ml , berry flavored off-white liquid.store clobazam oral suspension upright position . available follows : ndc 68094-066-584 ml per unit dose syringefifty ( 50 ) syringes per shipper ndc 68094-074-584 ml per unit dose enfit syringefifty ( 50 ) syringes per shipper",
    "adverseReactions": "clobazam oral suspension contraindicated patients history hypersensitivity ingredients . hypersensitivity included serious dermatological [ ( 5.6 ) ] .",
    "indications_original": "Clobazam oral suspension is indicated for the adjunctive treatment of seizures associated with Lennox-Gastaut syndrome (LGS) in patients 2 years of age or older.",
    "contraindications_original": "For doses above 5 mg/day administer in two divided doses. ( 2.1 ) Patients \u2264 30 kg body weight: Initiate at 5 mg daily and titrate as tolerated up to 20 mg daily. ( 2.1 ) Patients > 30 kg body weight: Initiate at 10 mg daily and titrate as tolerated up to 40 mg daily. ( 2.1 ) Dosage adjustment needed in following groups: Geriatric patients ( 2.4 , 8.5 ) Known CYP2C19 poor metabolizers ( 2.5 ) Mild or moderate hepatic impairment; no information for severe hepatic impairment ( 2.7 , 8.8 ) Oral suspension: Can be taken with or without food. ( 2.3 )",
    "warningsAndPrecautions_original": "Clobazam oral suspension, 2.5 mg/mL, is a berry flavored off-white liquid.Store clobazam oral suspension in an upright position. It is available as follows:\n                  NDC 68094-066-584 ml per unit dose syringeFifty (50) syringes per shipper\n                  NDC 68094-074-584 ml per unit dose ENFit syringeFifty (50) syringes per shipper",
    "adverseReactions_original": "Clobazam oral suspension is contraindicated in patients with a history of hypersensitivity to the drug or its ingredients. Hypersensitivity reactions have included serious dermatological reactions [see Warnings and Precautions (5.6)].",
    "drug": [
        {
            "name": "Clobazam",
            "chebi_id": "http://purl.obolibrary.org/obo/CHEBI_31413"
        }
    ]
}